29708-87-0Relevant articles and documents
Novel Chlorogenic Acid Derivatives and Composition for Treating Inflammatory Disease Comprising the Same
-
Paragraph 0179; 0180; 0181; 0182, (2017/08/02)
The present invention relates to a novel chlorogenic acid derivative compound having anti-inflammatory activities and an anti-inflammatory composition comprising the same as an active ingredient. The chlorogenic acid derivative compound of the present invention inhibits overproduction of nitrogen oxide (NO) induced by treating LPS in macrophage. The chlorogenic acid derivative compound of the present invention suppresses activation of NF-κB which is a signal transmission-mediated transcription factor significant in an oxidative stress and inflammation-promoting path. The chlorogenic acid derivative compound of the present invention can be developed as medicine for various inflammatory diseases by inhibiting overproduction of nitrogen oxide and activation of NF-κB.
Synthesis of 1-O-methylchlorogenic acid: Reassignment of structure for MCGA3 isolated from bamboo (Phyllostachys edulis) leaves
Zeller, Wayne E.
, p. 1860 - 1865 (2014/03/21)
The first synthesis of 1-O-methylchlorogenic acid is described. The short and efficient synthesis of this compound provides laboratory-scale quantities of the material to investigate its biological properties. The synthesis involves C-1 alkylation of the
Synthesis of designed acylquinic acid derivatives involved in blue color development of hydrangea and their co-pigmentation effect
Toyama-Kato, Yuki,Kondo, Tadao,Yoshida, Kumi
, p. 239 - 254 (2008/03/12)
The blue sepal color of hydrangea may be developed by an unstable stipramolecular metal-complex pigment composed of delphinidin 3-glucoside (1), 5-O-caffeoylquinic acid (2) and 5-O-p-coumaroylquinic acid (3) as co-pigments and Al3+ in aqueous s